Published on in Vol 6, No 10 (2022): October
![Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study](https://asset.jmir.pub/assets/73cfc17df1c5ef06313d2343f7fcd3ce.png 480w,https://asset.jmir.pub/assets/73cfc17df1c5ef06313d2343f7fcd3ce.png 960w,https://asset.jmir.pub/assets/73cfc17df1c5ef06313d2343f7fcd3ce.png 1920w,https://asset.jmir.pub/assets/73cfc17df1c5ef06313d2343f7fcd3ce.png 2500w)
1 Takeda Pharmaceuticals USA, Inc, Lexington, MA, United States
2 Cognition Kit, Cambridge, United Kingdom
3 Ctrl Group, London, United Kingdom
4 Cambridge Cognition, Cambridge, United Kingdom
5 Lundbeck LLC, Deerfield, IL, United States
6 Advocate Research Institute, Advocate Health Care, Downers Grove, IL, United States
7 Advocate Aurora Health, Downers Grove, IL, United States